QualTex Laboratories Honors Dr. Norman D. Kalmin
BioBridge Global is making a heartfelt move to rename its QualTex Laboratory facility in the Atlanta area, recognizing the dedicated service of its longtime executive, Dr. Norman D. Kalmin.
The Legacy of Dr. Kalmin
Dr. Kalmin dedicated over three decades to the organization, serving as chief executive for 27 years. He left a lasting impact when he retired in 2013, having played a key role in the laboratory's establishment in Norcross.
Testing and Services Offered
The newly named Dr. Norman D. Kalmin Laboratory is operationally crucial, performing essential FDA-approved testing on blood and blood plasma donations. Recently, they expanded to include a microbiology lab, enhancing their scope of specialized testing.
Growth of QualTex Laboratories
Originally founded in 2007 to provide necessary testing services for blood donations, QualTex Laboratories has grown significantly. It operates under the umbrella of BioBridge Global, which is a renowned nonprofit organization.
Expansion of Services
Opened in 2011, the Norcross location was introduced to serve as a backup testing center and support clients across the southeastern and eastern regions of the United States. This facility exemplifies commitment and efficiency in blood testing.
Innovative Advancements in Technology
In 2020, QualTex Laboratories proudly became the first commercial site to adopt the Abbott a3600 Accelerator automation system. This cutting-edge technology revolutionized testing speed and efficiency, allowing the lab to process over 50 million test results annually across its facilities.
Dr. Kalmin’s Leadership Journey
Dr. Kalmin began his journey at the South Texas Regional Blood Bank as medical director in 1983, later becoming the senior executive. His impressive foresight led to the organization's transformation into a comprehensive blood bank.
Transformational Changes in the Organization
His leadership marked a significant shift: evolving from a regional blood bank into a major player offering diverse services including testing, tissue collection, and cell-based therapies. A fundraising division, The Blood & Tissue Center Foundation, was established in 2001 under his direction.
International Recognition
The organization expanded from 150 employees to over 600 under Dr. Kalmin’s guidance, building partnerships across the United States and in regions including Europe, Asia, and Australia. They made history by becoming the first U.S. blood bank to achieve ISO certification.
Contributions Beyond Borders
In 2006, Dr. Kalmin’s extensive expertise earned him a position on a board within the International Society of Blood Transfusion, fostering improvements in global blood collection methods.
A Global Perspective
Originally from South Africa, Dr. Kalmin’s work in the United States began with a fellowship at the American Red Cross blood bank in Atlanta, where he solidified his citizenship. His transition from a newcomer to a leading expert showcases his determination and passion.
About BioBridge Global
BioBridge Global is a nonprofit healthcare services organization based in San Antonio, focused on transforming health care through its subsidiaries, including South Texas Blood & Tissue, QualTex Laboratories, and more. Their mission encompasses blood resource management, cellular therapies, and essential testing services.
About QualTex Laboratories
QualTex Laboratories stands as one of the largest nonprofit testing laboratories in the nation, providing advanced biologic testing services for blood, plasma, and human tissue. They are at the forefront of biotech and biopharmaceutical services and are dedicated to improving health outcomes globally.
Frequently Asked Questions
What is the significance of renaming the laboratory?
Renaming the laboratory after Dr. Kalmin acknowledges his invaluable contributions and long-standing service within the organization.
What services does QualTex Laboratories offer?
QualTex Laboratories offers biologic testing services on blood, plasma, human cells, and microbiology testing for the biotech sector.
When was the Norcross facility established?
The Norcross facility opened in 2011 to support expanded testing capabilities and serve as a backup location.
How has technology improved the laboratory's capabilities?
The introduction of the Abbott a3600 Accelerator automation system significantly increased testing speed and the volume of tests processed.
What is BioBridge Global's role in health care?
As a nonprofit organization, BioBridge Global focuses on providing crucial healthcare services, improving regenerative medicine, and enhancing lives through biological resources.
